XORTX Therapeutics Inc. Proceeds From Issue Of Ordinary Shares
XORTX Therapeutics Inc. (XRTX) reported Proceeds From Issue Of Ordinary Shares of CAD 22.80 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfOrdinaryShares · last filed 2022-05-03
| Period end | Proceeds From Issue Of Ordinary Shares 12 month |
|---|---|
| 2021-12-31 | 22.80M CAD 20-F · filed 2022-05-03 |
| 2020-12-31 | 900.00K CAD 20-F · filed 2022-05-03 |